PANews reported on June 20 that Parataxis Holdings, a startup focused on Bitcoin investment, has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion won (approximately 18.29 million USD), allowing Parataxis Holdings to gain a controlling stake in the company, with the aim of launching an institutionally supported Bitcoin financial platform in the Korean public market. This transaction will create a Bitcoin-native asset management platform in the Korean public market, supported by institutional investors with extensive experience in digital asset investment.
According to previous news, Parataxis Holdings plans to go public through a SPAC transaction, which still requires the completion of due diligence, signing of the final agreement, and obtaining regulatory approvals and other standard procedures.
